Compound Libraries

A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

119 tumor-targeted drugs that can be used for high-throughput and high-content screening.

A unique collection of 3580 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

Well-chosen 1468 anti-tumor compounds with unique structures;

A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；

A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；

A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;